Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.70 |
| ▸ | IDO1 | P14902 | 1/20 | 0.50 |
| ▸ | AGXT | P21549 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 5/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | CA9 | Q16790 | 3/20 | 0.45 |
| ▸ | CA7 | P43166 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | TACR1 | P25103 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30397113 | 0.97 | TSHR (0.67) | TSHRIDO1AGXTALDH1A1CA1 | |
| Phosphine SCHEMBL7705717 | 0.97 | TSHR (0.67) | TSHRIDO1AGXTALDH1A1CA1 | |
| SCHEMBL10660158 | 0.97 | TSHR (0.67) | TSHRIDO1AGXTALDH1A1CA1 | |
| Hydrochloric Acid SCHEMBL28406455 | 0.95 | TSHR (0.64) | TSHRIDO1AGXTALDH1A1CA1 | |
| Magnesium Chloride Anhydrous SCHEMBL28406453 | 0.93 | TSHR (0.61) | TSHRIDO1AGXTALDH1A1CA1 | |
| SCHEMBL344059 | 0.88 | TSHR (0.61) | TSHRIDO1AGXTALDH1A1CA1 | |
| SCHEMBL71046 | 0.88 | TSHR (0.61) | TSHRIDO1AGXTALDH1A1CA1 | |
| Methylene Chloride SCHEMBL27690292 | 0.86 | TSHR (0.83) | TSHRIDO1AGXTALDH1A1CA1 | |
| SCHEMBL14947971 | 0.86 | TSHR (0.48) | TSHRIDO1AGXTALDH1A1CA2 | |
| SCHEMBL25310046 | 0.84 | TSHR (0.56) | TSHRIDO1AGXTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3682 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122079847-A | Key intermediate of 3-hydroxymethyl azetidine-1-carboxylic acid tert-butyl ester and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-119638697-A | ERVITSINE total synthesis method | 南方科技大学 | 2025-03-18 | — | — | CN | claimed |
| CN-119528820-A | Apricoxiyet Synthesis method of tam | 浙江国邦药业有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-118807509-A | Modified polysulfone membrane and preparation method thereof | 清华大学 | 2024-10-22 | — | — | CN | claimed |
| US-20240279225-A1 | COMPOUNDS AND METHODS FOR THERANOSTIC TARGETING OF PARP ACTIVITY | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-08-22 | — | — | US | claimed |
| CN-118348192-A | Method for detecting total chlorine of benzyl chloromethyl ether | 江西亚太科技发展有限公司 | 2024-07-16 | — | — | CN | claimed |
| CN-113024359-B | Process for preparing alkoxymethyl alkynyl ether compounds having terminal triple bonds | 信越化学工业株式会社 | 2024-06-11 | — | — | CN | claimed |
| CN-118063409-A | Preparation method of cefdinir and intermediate thereof | 江苏美迪克化学品有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-117976970-A | Electrolyte, battery monomer, preparation method of battery monomer, battery and power utilization device | 宁德时代新能源科技股份有限公司 | 2024-05-03 | — | — | CN | claimed |
| WO-2024087799-A1 | ELECTROLYTE, BATTERY CELL AND PREPARATION METHOD THEREFOR, BATTERY, AND ELECTRIC DEVICE | 宁德时代新能源科技股份有限公司 | 2024-05-02 | — | — | WO | claimed |
| US-6566553-B2 | Synthetic pathway relies upon stereospecific synthesis of oxazoline intermediate and stereoselective addition of formyl amide to oxazoline | MILLENNIUM PHARMACEUTICALS, INC. | 2003-05-20 | — | — | US | claimed |
| US-20020016355-A1 | Synthesis of clasto-lactacystin beta-lactone and analogs thereof | SOUCY FRANCOIS (US) | 2002-02-07 | — | — | US | claimed |
| CN-1321632-A | (4S,5S)-and (4R,5R)-gamma-methyl-delta-hydroxyl-alkanoic acid and its alkyl ester, preparation method and application | SHANGHAI INST ORGANIC CHEM (CN) | 2001-11-14 | — | — | CN | claimed |
| EP-1021407-A4 | SYNTHESIS OF CLASTO-LACTACYSTIN BETA-LACTONE AND ANALOGS THEREOF | MILLENNIUM PHARM INC (US) | 2001-07-04 | — | — | EP | claimed |
| CN-1271342-A | Synthesis of clasto-lactacystin-beta-lactone and analogs thereof | SOUCY F (US) | 2000-10-25 | — | — | CN | claimed |
| EP-1021407-A1 | SYNTHESIS OF CLASTO-LACTACYSTIN BETA-LACTONE AND ANALOGS THEREOF | Millennium Pharmaceuticals, Inc. (US) | 2000-07-26 | — | — | EP | claimed |
| WO-1999009006-A1 | SYNTHESIS OF CLASTO-LACTACYSTIN β-LACTONE AND ANALOGS THEREOF | SOUCY FRANCOIS (US) | 1999-02-25 | — | — | WO | claimed |
| WO-1998046577-A1 | NOVEL OXAZOLIDINONES AND METHODS FOR THE SYNTHESIS AND USE OF SAME | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1998-10-22 | — | — | WO | claimed |
| EP-0377031-A1 | 5-DEAZA-5,7-DISUBSTITUTED-AMINOPTERIN ANALOGUES | Sloan-Kettering Institute For Cancer Research (US) | 1990-07-11 | — | — | EP | claimed |
| WO-1990000172-A1 | 5-DEAZA-5,7-DISUBSTITUTED-AMINOPTERIN ANALOGUES | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1990-01-11 | — | — | WO | claimed |